Men Are Gaining More Confidence From Ozempic Than Women: Report
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
While some may associate Ozempic and other GLP-1 medications with women trying to lose weight, it turns out that men are the ones gaining the most significant confidence boosts from it.
In a Kinsey Institute and DatingAdvice.com survey of GLP-1 users, men were three times more likely than women to say GLP-1s gave them more confidence. They also experienced more notable improvements in their dating lives and libidos.
Why It Matters
In recent years, the use of weight-loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists has surged.
Popular products include Ozempic, Mounjaro, Wegovy and Zephound and have been a game changer for many Americans who are obese or have type 2 diabetes.
For patients who successfully lose weight, there can be significant changes in their mental health as well as their personal dating lives, but this impact appears to be more pronounced among male users.
Ozempic is medicine for adults with type 2 diabetes. Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient semaglutide, on January 13, 2025, in Sydney, Australia.
Ozempic is medicine for adults with type 2 diabetes. Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient semaglutide, on January 13, 2025, in Sydney, Australia.
Steve Christo - Corbis/Corbis via Getty Images
What To Know
Across the entire survey sample, drugs like Ozempic were having major effects on users' dating lives. While 59 percent of users said the drugs changed their dating experiences, men experienced a more notable impact on their confidence levels and sex lives, according to the report.
Men were three times more likely than women to say GLP-1s boosted their confidence and two times more likely to say they were going on more dates. They also reported higher libido, more matches and increased sexual activity.
Still, there were some negative implications for men, of which 60 percent said they feared being judged for using GLP-1s and worried they'd be seen as "less masculine" for doing so.
Of all GLP-1 users surveyed, 12 percent said they were going on more dates, and 14 percent said they were getting more matches on dating apps. Meanwhile, a whopping 52 percent reported changes in their sex lives.
What People Are Saying
Dr. Justin Lehmiller, the Kinsey Institute study lead, said in a statement: "I think there's a very nuanced story to tell here. How these drugs impact your sex life will depend on a variety of factors, including drug dosage and drug type, speed of weight loss, starting and ending weight, and how much you changed your health and fitness habits at the same time."
"Sexually speaking, it appears that men are experiencing more positive and more negative impacts of GLP-1 medications."
What Happens Next
The long-term implications of GLP-1 medication use are so far unclear.
A recent study discovered a new link between taking GLP-1 drugs and elevated risk of pancreatitis and kidney conditions, including kidney stones.
GLP-1 medications are also associated with a higher risk of digestive problems, including nausea, vomiting, diarrhea, and even stomach paralysis in rare cases.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
43 minutes ago
- Business Wire
As health benefit costs continue to surge, Mercer's research reveals that employers face tough decisions regarding their 2026 benefit offerings
NEW YORK--(BUSINESS WIRE)-- Mercer, a business of Marsh McLennan (NYSE: MMC) and a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people, today released its Survey on Health and Benefit Strategies for 2026. According to the survey, more employers will likely reduce benefits in 2026 as they try to control fast-growing health benefit costs. In recent years, the tight labor market and concerns about healthcare affordability have made employers reluctant to reduce the value of health benefits by raising deductibles or making other changes that shift more responsibility for healthcare cost to employees. But this year, more employers seem likely to use this tactic to slow health plan cost growth. Half (51%) of large employers (those with 500 or more employees) say they are likely or very likely to make plan design changes in 2026 that would shift more cost to employees, such as raising deductibles or out-of-pocket maximums. That's up from 45% in last year's survey. 'Employers project average health benefit costs to grow by nearly 6% this year, and 2026 may be even more challenging from a cost perspective,' said Ed Lehman, Mercer's US Health & Benefits Leader. 'While short-term cost containment actions might be needed to address current budget realities, we also see some employers using longer-term strategies, such as offering narrow network plans, that emphasize high-quality, high-value care. These strategies may improve health outcomes or make healthcare more affordable for employees." Some employers will pursue other strategies to slow cost growth. According to the survey, 35% of large employers will offer a non-traditional medical plan option in 2026 that seeks to provide employees with higher-quality, more cost-efficient care. Employers offer these alternative plans to provide choices to employees with a range of medical and financial needs. Variable copay plans are one example and typically offer no or low deductibles and set copayments for services based on individual providers' fees. These copays are fixed and communicated up front, giving members the opportunity to select lower-cost providers. The survey found that among the 6% of large employers currently offering a variable copay plan, 28% of their covered employees, on average, chose to enroll in them in 2025. Weight-loss medication cost is a top concern Sharp growth in the utilization of glucagon-like peptide 1 (GLP-1) drugs for the treatment of diabetes and obesity is having a significant impact on prescription drug benefit costs. While employers have long covered GLP-1 drugs for diabetes, fewer than half (44%) of large employers cover the drugs specifically approved to treat obesity. Given the high cost of these drugs (about $1,000 per month per patient, not counting manufacturers' rebates, which vary), and the large number of plan members that could potentially benefit from them, managing this cost is by far the top priority in pharmacy benefits among survey respondents, with 77% saying it is extremely or very important. 'While the trend over the past couple of years has been to add coverage for GLP-1s approved for weight-loss, some employers facing large cost increases in 2026 may feel this coverage is out of reach,' says Alysha Fluno, Mercer's Pharmacy Innovation Leader. 'Employers are weighing the immediate costs of covering these drugs against the potential for generating savings down the road once their workforce's health improves.' More broadly, some employers are evaluating new approaches to providing and managing the costs of pharmacy benefits. Well over half of large employers (61%) are now actively exploring some type of alternative to standard pharmacy benefit contracts that would potentially provide greater clarity about the cost of drugs or specific services offered by pharmacy benefit managers. Well-being and mental health continue to be a priority Employers remain committed to helping employees manage stress and build coping skills, which may help prevent the onset of more serious mental health issues. More than 75% of large employers will offer digital stress management or resiliency resources in 2026, such as mindfulness and meditation apps, or apps grounded in cognitive behavioral therapy. Half (51%) will offer in-person or live online resources for stress management and resiliency, such as individual or group training sessions or coaching. Employers are also providing training for managers on how to recognize employees who are struggling with their mental health, offer support and direct them to resources. This type of training is increasingly recognized as a strategy for fostering a healthy workplace. Nearly 40% of all large employers surveyed – and 60% of those with 20,000 or more employees – conduct mental health training for managers. These efforts may be a response to a growing need. According to Mercer's research, nearly half (45%) of US employees feel stressed most days at work. About Mercer's Survey on Health and Benefit Strategies for 2026 This study includes 711 US-based organizations (504 organizations with 500 or more employees and 207 organizations with fewer than 500 employees). The study was fielded between April 8 and April 25, 2025. Click here to learn more. About Mercer Mercer, a business of Marsh McLennan (NYSE: MMC), is a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people. Marsh McLennan is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit or follow on LinkedIn and X.
Yahoo
44 minutes ago
- Yahoo
As health benefit costs continue to surge, Mercer's research reveals that employers face tough decisions regarding their 2026 benefit offerings
NEW YORK, July 16, 2025--(BUSINESS WIRE)--Mercer, a business of Marsh McLennan (NYSE: MMC) and a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people, today released its Survey on Health and Benefit Strategies for 2026. According to the survey, more employers will likely reduce benefits in 2026 as they try to control fast-growing health benefit costs. In recent years, the tight labor market and concerns about healthcare affordability have made employers reluctant to reduce the value of health benefits by raising deductibles or making other changes that shift more responsibility for healthcare cost to employees. But this year, more employers seem likely to use this tactic to slow health plan cost growth. Half (51%) of large employers (those with 500 or more employees) say they are likely or very likely to make plan design changes in 2026 that would shift more cost to employees, such as raising deductibles or out-of-pocket maximums. That's up from 45% in last year's survey. "Employers project average health benefit costs to grow by nearly 6% this year, and 2026 may be even more challenging from a cost perspective," said Ed Lehman, Mercer's US Health & Benefits Leader. "While short-term cost containment actions might be needed to address current budget realities, we also see some employers using longer-term strategies, such as offering narrow network plans, that emphasize high-quality, high-value care. These strategies may improve health outcomes or make healthcare more affordable for employees." Some employers will pursue other strategies to slow cost growth. According to the survey, 35% of large employers will offer a non-traditional medical plan option in 2026 that seeks to provide employees with higher-quality, more cost-efficient care. Employers offer these alternative plans to provide choices to employees with a range of medical and financial needs. Variable copay plans are one example and typically offer no or low deductibles and set copayments for services based on individual providers' fees. These copays are fixed and communicated up front, giving members the opportunity to select lower-cost providers. The survey found that among the 6% of large employers currently offering a variable copay plan, 28% of their covered employees, on average, chose to enroll in them in 2025. Weight-loss medication cost is a top concern Sharp growth in the utilization of glucagon-like peptide 1 (GLP-1) drugs for the treatment of diabetes and obesity is having a significant impact on prescription drug benefit costs. While employers have long covered GLP-1 drugs for diabetes, fewer than half (44%) of large employers cover the drugs specifically approved to treat obesity. Given the high cost of these drugs (about $1,000 per month per patient, not counting manufacturers' rebates, which vary), and the large number of plan members that could potentially benefit from them, managing this cost is by far the top priority in pharmacy benefits among survey respondents, with 77% saying it is extremely or very important. "While the trend over the past couple of years has been to add coverage for GLP-1s approved for weight-loss, some employers facing large cost increases in 2026 may feel this coverage is out of reach," says Alysha Fluno, Mercer's Pharmacy Innovation Leader. "Employers are weighing the immediate costs of covering these drugs against the potential for generating savings down the road once their workforce's health improves." More broadly, some employers are evaluating new approaches to providing and managing the costs of pharmacy benefits. Well over half of large employers (61%) are now actively exploring some type of alternative to standard pharmacy benefit contracts that would potentially provide greater clarity about the cost of drugs or specific services offered by pharmacy benefit managers. Well-being and mental health continue to be a priority Employers remain committed to helping employees manage stress and build coping skills, which may help prevent the onset of more serious mental health issues. More than 75% of large employers will offer digital stress management or resiliency resources in 2026, such as mindfulness and meditation apps, or apps grounded in cognitive behavioral therapy. Half (51%) will offer in-person or live online resources for stress management and resiliency, such as individual or group training sessions or coaching. Employers are also providing training for managers on how to recognize employees who are struggling with their mental health, offer support and direct them to resources. This type of training is increasingly recognized as a strategy for fostering a healthy workplace. Nearly 40% of all large employers surveyed – and 60% of those with 20,000 or more employees – conduct mental health training for managers. These efforts may be a response to a growing need. According to Mercer's research, nearly half (45%) of US employees feel stressed most days at work. About Mercer's Survey on Health and Benefit Strategies for 2026 This study includes 711 US-based organizations (504 organizations with 500 or more employees and 207 organizations with fewer than 500 employees). The study was fielded between April 8 and April 25, 2025. Click here to learn more. About Mercer Mercer, a business of Marsh McLennan (NYSE: MMC), is a global leader in helping clients realize their investment objectives, shape the future of work and enhance health and retirement outcomes for their people. Marsh McLennan is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit or follow on LinkedIn and X. View source version on Contacts Media contact:Cassie LenskiMercer+1 214 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Newsweek
an hour ago
- Newsweek
Obese-Shaming Video Trend Causes Stir Online
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A new trend is going viral on social media: AI-generated videos of people who are overweight in social scenarios where they are causing chaos, seemingly as a result of their size. Why It Matters While the 2010s saw body positivity become a mainstay in the cultural lexicon, the 2020s have borne witness to a proliferation of thinness discourse in online spaces—be it through #skinnytok or the increasing ubiquity of weight loss drugs such as Ozempic. The shift has sparked an increase in stigma toward larger people. Tanis Jex-Blake, center, and supporters during a bikini protest in Edmonton, Alberta, on August 6, 2014. Tanis Jex-Blake, center, and supporters during a bikini protest in Edmonton, Alberta, on August 6, 2014. AP Photo/The Canadian Press, Jason Franson What To Know In one video, shared by the TikTok account @charmbustersofc, a plus-size woman jumps off a diving board into the sea and causes a ripple of splashes so gigantic that boats capsize. The video has been viewed 4.1 million times. Plus-size people capsizing boats is a common theme in this content. One AI-generated video of a woman jumping off a boat and capsizing it has been viewed 414 million times on Instagram alone. That same account also posted a video of a plus-size ice skater crushing a smaller one. Another video posted by the account @aiiscursed shows an overweight monster walking through a store, and the TikTok account @obeseverseoriginal is seemingly dedicated to showing AI-generated overweight depictions of classic superhero characters such as Batman and Superman. Newsweek spoke with Heather Widdows, the author of Perfect Me and a professor of philosophy at the University of Warwick in England. "There is a fascination with fatness—something we fear and revile—and far more than is justified by any concern for health," she said. "As appearance becomes more important in our culture, failing to make the grade is to fall outside what's acceptable. Fatness represents what's not OK, what we don't want to be, something almost alien," Widdows added. The most recent Vogue Business size-inclusivity report, published in March, said size inclusivity had declined once again—continuing a trend seen in other recent seasons. The report—analyzing Fashion Weeks across New York, Milan, London and Paris this year—said, "Of the 8,703 looks presented across 198 shows and presentations, 97.7 percent were straight-size (U.S. 0-4), 2 percent were midsize (U.S. 6-12) and 0.3 percent were plus-size (U.S. 14+)." This isn't the first AI trend of its kind. In March, a TikTok filter referred to as an AI "chubby" filter, allowed users to edit photos of themselves to look larger, causing outrage on the platform until it was removed. TikTok also banned #skinnytok, which critics said was promoting extreme thinness. The platform blocked searches for the hashtag in June and now directs users to mental health support resources. The response to these videos has been mixed, with some social media users filling the comments sections with laughing emoji while others point out that the videos use AI. However, the reaction to the types of bodies in the videos is clearer. One social media user wrote: "Never having a McDonald's again. lol." Another commented, "Some thing to remind you to weigh your passengers before taking risks like this." Widdows said: "The people posting these fat posts think it's OK to laugh because, hey, it's only pretend fat people. The same people probably wouldn't think it's OK if it were their grandma or someone's grandma." "But it sends a message that it's OK to laugh at fat people," she continued. Widdows added that this "implies that fat people are fair game—they can be blamed and shamed. Fat-shaming is often treated as if it's acceptable, though we know it cuts deep and has impact that is at least as harmful as other forms of discrimination." What People Are Saying Heather Widdows, a professor of philosophy at the University of Warwick, told Newsweek: "The thin-ideal is globally powerful and dominant and with the other three features of the beauty ideal—firmness, smoothness and youth—is a powerful taskmaster. We want to be thin—in the right way, with curves in the right places—and we fear not being, of 'letting ourselves go.' Fat-shaming says as much about the shamer as the shamee. It says: 'I'm afraid of being fat. I care about thinness.'" What Happens Next It remains to be seen whether social media platforms will regulate this content.
